Literature DB >> 23737133

Vacuolar protein sorting 4B, an ATPase protein positively regulates the progression of NSCLC via promoting cell division.

Yifei Liu1, Liting Lv, Qun Xue, Chunhua Wan, Tingting Ni, Buyou Chen, Yanhua Liu, Yiqun Zhou, Runzhou Ni, Guoxin Mao.   

Abstract

Vacuolar protein sorting 4B (VPS4B), a member of ATPase family proteins, plays a crucial role in lysosome-dependent degradation. Recently, it was found that VPS4B could negatively regulate breast cancer progression through promoting lysosomal-dependent degradation for EGFR. Nevertheless, other studies found that VPS4B was also essential for cell division and mitosis through insuring the maintenance of centrosome and spindle assembly. Thus, the role of VPS4B in cancer biology remains under debate. In this study, we analyzed the clinical significance of VPS4B in NSCLC. The expression of VPS4B was evaluated by Western blot in 8 paired fresh NSCLC tissues and immunohistochemistry on 105 paraffin-embedded slices. VPS4B was highly expressed in NSCLC and significantly associated with NSCLCs tumor size, histological differentiation, clinical stage and Ki-67. Besides, high VPS4B expression was an independent prognostic factor for NSCLC patients' poor survival. To determine whether VPS4B could regulate the proliferation of NSCLC cells, we knocked down the expression of VPS4B and analyzed the proliferation of A549 NSCLC cells using Western blot, CCK8 and flow cytometry assays, which together indicated that loss of VPS4B could inhibit cell cycle progress. These data suggest that VPS4B may promote the progression of NSCLC and be a biotarget for NSCLCs therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23737133     DOI: 10.1007/s11010-013-1699-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  31 in total

1.  Cholesterol depletion facilitates ubiquitylation of NPC1 and its association with SKD1/Vps4.

Authors:  Yuki Ohsaki; Yuko Sugimoto; Michitaka Suzuki; Hiroshi Hosokawa; Tamotsu Yoshimori; Joanna P Davies; Yiannis A Ioannou; Marie T Vanier; Kousaku Ohno; Haruaki Ninomiya
Journal:  J Cell Sci       Date:  2006-06-06       Impact factor: 5.285

Review 2.  ESCRTing proteins in the endocytic pathway.

Authors:  Suraj Saksena; Ji Sun; Tony Chu; Scott D Emr
Journal:  Trends Biochem Sci       Date:  2007-11-07       Impact factor: 13.807

3.  Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection.

Authors:  Huixin Yao; Zhiqiang Zhang; Zhiqiang Xiao; Yongheng Chen; Cui Li; Pengfei Zhang; Meixiang Li; Yingfu Liu; Yongjun Guan; Yanhui Yu; Zhuchu Chen
Journal:  Lung Cancer       Date:  2008-12-05       Impact factor: 5.705

4.  A dominant negative form of the AAA ATPase SKD1/VPS4 impairs membrane trafficking out of endosomal/lysosomal compartments: class E vps phenotype in mammalian cells.

Authors:  Hideaki Fujita; Motoko Yamanaka; Kanako Imamura; Yoshitaka Tanaka; Atsuki Nara; Tamotsu Yoshimori; Sadaki Yokota; Masaru Himeno
Journal:  J Cell Sci       Date:  2003-01-15       Impact factor: 5.285

5.  Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.

Authors:  J Geradts; K M Fong; P V Zimmerman; R Maynard; J D Minna
Journal:  Clin Cancer Res       Date:  1999-04       Impact factor: 12.531

6.  Human ESCRT-III and VPS4 proteins are required for centrosome and spindle maintenance.

Authors:  Eiji Morita; Leremy A Colf; Mary Anne Karren; Virginie Sandrin; Christopher K Rodesch; Wesley I Sundquist
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-29       Impact factor: 11.205

7.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

8.  The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer.

Authors:  Madhu S Kumar; David C Hancock; Miriam Molina-Arcas; Michael Steckel; Phillip East; Markus Diefenbacher; Elena Armenteros-Monterroso; François Lassailly; Nik Matthews; Emma Nye; Gordon Stamp; Axel Behrens; Julian Downward
Journal:  Cell       Date:  2012-04-27       Impact factor: 41.582

9.  Significance of Jab1 expression in human esophageal squamous cell carcinoma.

Authors:  Feng Wang; Yuchan Wang; Xiaowei Yu; Dicheng Yang; Zheng Wang; Chengbao Lu; Zhongxiang Yuan; Mingdi Xiao; Aiguo Shen
Journal:  J Clin Gastroenterol       Date:  2009-07       Impact factor: 3.062

10.  Involvement of host cellular multivesicular body functions in hepatitis B virus budding.

Authors:  Tokiko Watanabe; Ericka M Sorensen; Akira Naito; Meghan Schott; Seungtaek Kim; Paul Ahlquist
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-05       Impact factor: 11.205

View more
  12 in total

1.  Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes.

Authors:  Hyang Sook Seol; Yoshimitsu Akiyama; Shu Shimada; Hee Jin Lee; Tae Im Kim; Sung Min Chun; Shree Ram Singh; Se Jin Jang
Journal:  Cancer Lett       Date:  2014-07-22       Impact factor: 8.679

2.  Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.

Authors:  Xiaoli Li; Jian Liu; Li Qian; Honggang Ke; Chan Yao; Wei Tian; Yifei Liu; Jianguo Zhang
Journal:  Mol Cell Biochem       Date:  2018-01-11       Impact factor: 3.396

3.  The expression changes of vacuolar protein sorting 4B (VPS4B) following middle cerebral artery occlusion (MCAO) in adult rats brain hippocampus.

Authors:  Gang Cui; Yunfeng Wang; Shanshan Yu; Lixiang Yang; Bing Li; Wei Wang; Peng Zhou; Jiang Wu; Ting Lu; Dongjian Chen
Journal:  Cell Mol Neurobiol       Date:  2014-01       Impact factor: 5.046

4.  Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis.

Authors:  Tingting Ni; Guoxin Mao; Qun Xue; Yifei Liu; Buyou Chen; Xuefan Cui; Liting Lv; Liangliang Jia; Yuchan Wang; Lili Ji
Journal:  J Mol Histol       Date:  2015-06-10       Impact factor: 2.611

5.  VPS52 induces apoptosis via cathepsin D in gastric cancer.

Authors:  Jian Zhang; Ying Lin; Xichun Hu; Zheng Wu; Weijian Guo
Journal:  J Mol Med (Berl)       Date:  2017-08-08       Impact factor: 4.599

6.  Cell adhesion down-regulates the expression of vacuolar protein sorting 4B (VPS4B) and contributes to drug resistance in multiple myeloma cells.

Authors:  Jie Tang; Lili Ji; Yuchan Wang; Yuejiao Huang; Haibing Yin; Yunhua He; Jing Liu; Xiaobing Miao; Yaxun Wu; Xiaohong Xu; Song He; Chun Cheng
Journal:  Int J Hematol       Date:  2015-03-25       Impact factor: 2.490

7.  Upregulation of SYF2 in esophageal squamous cell carcinoma promotes tumor cell proliferation and predicts poor prognosis.

Authors:  Junya Zhu; Lili Ji; Jianguo Zhang; Lei Yang; Chengqi Guan; Yayun Wang; Jia Zhu; Li Liang; Runzhou Ni
Journal:  Tumour Biol       Date:  2014-07-18

8.  Expression and clinical role of NF45 as a novel cell cycle protein in esophageal squamous cell carcinoma (ESCC).

Authors:  Sujie Ni; Junya Zhu; Jianguo Zhang; Shu Zhang; Mei Li; Runzhou Ni; Jinxia Liu; Huiyuan Qiu; Wenjuan Chen; Huijie Wang; Weijian Guo
Journal:  Tumour Biol       Date:  2014-10-08

9.  Expression of Kruppel-like factor 8 and Ki67 in lung adenocarcinoma and prognosis.

Authors:  Yifei Liu; Xiufang Yao; Qing Zhang; Li Qian; Jia Feng; Tingting Bian; Jianguo Zhang; Ye Tian
Journal:  Exp Ther Med       Date:  2017-06-20       Impact factor: 2.447

10.  Synthetic lethality between VPS4A and VPS4B triggers an inflammatory response in colorectal cancer.

Authors:  Ewelina Szymańska; Paulina Nowak; Krzysztof Kolmus; Magdalena Cybulska; Krzysztof Goryca; Edyta Derezińska-Wołek; Anna Szumera-Ciećkiewicz; Marta Brewińska-Olchowik; Aleksandra Grochowska; Katarzyna Piwocka; Monika Prochorec-Sobieszek; Michał Mikula; Marta Miączyńska
Journal:  EMBO Mol Med       Date:  2020-01-13       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.